Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. SMD Rise PCL's annualized net income for the quarter that ended in Mar. 2026 was ฿-122.2 Mil. SMD Rise PCL's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ฿696.0 Mil. Therefore, SMD Rise PCL's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was -17.55%.
The historical rank and industry rank for SMD Rise PCL's Return-on-Tangible-Equity or its related term are showing as below:
BKK:SMD100-R'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 0.94 Med: 29.2 Max: 57.22
Current: 0.94
During the past 8 years, SMD Rise PCL's highest Return-on-Tangible-Equity was 57.22%. The lowest was 0.94%. And the median was 29.20%.
BKK:SMD100-R's Return-on-Tangible-Equity is ranked worse than 78.38% of 111
companies
in the Medical Distribution industry
Industry Median: 9.07
vs BKK:SMD100-R: 0.94
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
SMD Rise PCL Return-on-Tangible-Equity Related Terms
SMD Rise PCL Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for SMD Rise PCL's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SMD100-R vs MCK, COR, CAH: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, SMD Rise PCL's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMD Rise PCL Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where SMD Rise PCL's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -17.55% mean?
SMD Rise PCL (BKK:SMD100-R) has a Return-on-Tangible-Equity of -17.55% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on SMD Rise PCL and its competitors. Over the past decade, SMD Rise PCL's Return-on-Tangible-Equity has ranged from 0.94 to 57.22. According to the industry distribution chart, SMD Rise PCL ranks #87 out of 111 companies in the Medical Distribution industry, placing it in the top 78.4%.
Is SMD Rise PCL's Return-on-Tangible-Equity too high?
SMD Rise PCL's current Return-on-Tangible-Equity is -17.55%. Over the past 10 years, this metric has ranged from a low of 0.94 to a high of 57.22. Based on the distribution chart, SMD Rise PCL ranks #87 out of 111 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, SMD Rise PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's Return-on-Tangible-Equity compare to MCK and COR?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #87 out of 111 companies for Return-on-Tangible-Equity. This places SMD Rise PCL in the lower half of its industry. The industry median Return-on-Tangible-Equity is 9.07. Historically, SMD Rise PCL's own Return-on-Tangible-Equity has ranged from 0.94 to 57.22 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 9.07, based on 111 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on SMD Rise PCL and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 9.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current Return-on-Tangible-Equity is -17.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current Return-on-Tangible-Equity of -17.55%. The stock's GF Value™ is ฿24.66, compared to a current price of ฿5.85 — trading 76.3% below its estimated fair value. The current Return-on-Tangible-Equity is -17.55%. SMD Rise PCL's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current Return-on-Tangible-Equity is -17.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿5.85 is trading 76.3% below its estimated GF Value™ of ฿24.66.
Key valuation signals for BKK:SMD100-R:
Return-on-Tangible-Equity: -17.55%
GF Value™: ฿24.66 vs. price of ฿5.85 (76.3% below fair value)
No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
59GF Score
Get the complete analysis for BKK:SMD100-R
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100-R has been successfully added to your 
